Eurobio Scientific Société anonyme (EPA:ALERS)

Market Cap	229.56M -5.2%
Revenue (ttm)	169.00M +9.1%
Net Income	4.90M +22.6%
EPS	n/a
Shares Out	10.07M
PE Ratio	46.85
Forward PE	20.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	209
Average Volume	519
Open	22.70
Previous Close	22.80
Day's Range	22.70 - 24.00
52-Week Range	20.40 - 25.95
Beta	0.68
RSI	55.24
Earnings Date	Apr 10, 2026

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune stat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 320
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2025, EPA:ALERS's revenue was 169.00 million, an increase of 9.07% compared to the previous year's 154.95 million. Earnings were 4.90 million, an increase of 22.56%.